Printer Friendly

First report of an anti-tumor, anti-fungal, anti-yeast and anti-bacterial hemolysin from Albizia lebbeck seeds.


A monomeric 5.5-kDa protein with hemolytic activity toward rabbit erythrocytes was isolated from seeds of Albizia lebbeck by using a protocol that involved ion-exchange chromatography on Q-Sepharose and SP-Sepharose, hydrophobic interaction chromatography on Phenyl-Sepharose, and gel filtration on Superdex 75. It was unadsorbed on both Q-Sepharose and SP-Sepharose, but adsorbed on Phenyl-Sepharose. Its hemolytic activity was fully preserved in the pH range 0-14 and in the temperature range 0-100[degrees]C, and unaffected in the presence of a variety of metal ions and carbohydrates. The hemolysin reduced viability of murine splenocytes and inhibited proliferation of MCF-7 breast cancer cells and HepG2 hepatoma cells with an [IC.sub.50] of 0.21, 0.97, and 1.37 [mu]M, respectively. It impeded mycelial growth in the fungi Rhizoctonia solani with an IC50 of 39 [mu]M but there was no effect on a variety of other filamentous fungi, including Fusarium oxysporum, Helminthosporium maydis, Valsa mali and Mycosphaerella arachidicola, Lebbeckalysin inhibited growth of Escherichia coli with an IC50 of 0.52 [mu]M.

[C] 2010 Elsevier GmbH. All rights reserved.



Albizia lebbeck







Hemolysins are produced by bacteria in order to obtain nutrients from host cells. The concentration of free iron within the body of an animal is very low. However, red blood cells are rich in iron-containing heme. Release of heme by lysing red blood cells with hemolysin allows the bacteria to take up the free iron (Sritharan 2006). Furthermore, many bacterial pathogens produce toxins that kill and lyse host red blood cells. Most of them are pore-forming proteins (Alouf 2001). So, most of the hemolysins were purified from bacteria (Mudenda Hang'ombe et al. 2006; Rozalska and Szewczyk 2008).

Apart from pore-forming activity, hemolysins may have antifungal (Abe and Nakazawa 1994), anti-bacterial (Ngai and Ng 2006), and antiproliferative (Berne et al. 2009) activities. So, they are classified as defense proteins.

Albizia lebbeck is a species of Albizia, native to tropical southern Asia, and widely cultivated and naturalized in other tropical and subtropical regions. It has various common names including Lebbeck, Lebbek Tree, Flea Tree, Frywood, Koko and Woman's tongues Tree. Its uses comprise environmental management, forage, medicine and wood. Plantation of A lebbeck can reduce heavy metal concentrations in the redeveloping soil of mine spoil (Singh et al.2005).

The bark of A lebbeck demonstrates anti-inflammatory (Babu et al. 2009; Saha and Ahmed 2009) and analgesic (Saha and Ahmed 2009) activities. Saponins (Gupta et al. 2005) isolated from bark show antispermatogenic and antiandrogenic activities (Gupta et al. 2006). Different saponins have been identified from the leaves (el-Mousallamy 1998) and bark (Pal et al. 1995) of A lebbeck. Furthermore, it is one of the ingredients in a formulation for allergic rhinitis (Amit et al. 2003).

In view of the diversity of hemolysins and the meager information about the protein constituents of A lebbeck seeds that is available, we undertook the present investigation to isolate a hemolysin from this source. The results indicate that the isolated hemolysin possesses some distinctive characteristics.

Materials and methods

Purification of hemolysin

Fresh seeds of A lebbeck (130 g) collected from an A lebbeck tree were homogenized. Following centrifugation, the supernatant was applied on a 14 cm x 5 cm Q-Sepharose (GE Healthcare) column in 10mM [NH.sub.4] [HCO.sub.3] (pH 9.4). Adsorbed proteins were eluted with 1 M NaCl added to the [NH.sub.4] [HCO.sub.3] buffer. The unadsorbed fraction was dialyzed, and then chromatographed on a 14 cm x 5 cm SP-Sepharose (GE Healthcare) column in 10 mM ammonium acetate (pH 4.6). Adsorbed proteins were eluted with 1 M NaCl added to the NH4OAC buffer. The unadsorbed fraction was dialyzed, and diluted with the same volume of 3 M ammonium sulfate containing 40 mM Tris-HCl buffer (pH 7.6) before chromatography on an 8 cm x 5 cm Phenyl-Sepharose (GE Healthcare) column. Adsorbed proteins, eluted with 20 mM Tris-HCl (pH 7.6), were collected, dialyzed and lyophilized before chromatography on a Superdex 75 10/300 GL column (GE Healthcare) in 150mM ammonium bicarbonate (pH 7.2), previously calibrated with molecular mass markers. The last fraction represented purified hemolysin (5.5 kDa), which was designated as lebbeckalysin.

Molecular mass determination using sodium dodecyl sulfate-polyaayiamide gel electrophoresis, gel filtration, and N-terminal amino acid sequencing

Purified lebbeckalysin was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions (Laemmli and Favre, 1973). After electrophoresis, the gel was stained with Coomassie Blue R-250. Gel filtration on a fast protein liquid chromatography Superdex 75 10/300 GL column (GE Healthcare) using an AKTA Purifier (GE Healthcare) was conducted to determine the molecular mass of the lebbeckalysin. The column had been calibrated with molecular mass markers, including blue dextran 2000 (to determine void volume), bovine serum albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A (25 kDa), myoglobulin (17.6 kDa), ribonuclease A (13.7 kDa), aprotinin (6.5 kDa) and vitamin B12 (1.3 kDa) (GE Healthcare). The N-terminal sequence of lebbeckalysin was determined as described by Urn and Ng (2009b).

Assay of hemolytic activity

Rabbit erythrocytes were washed with phosphate-buffered saline (PBS, pH 7.5) and adjusted to a final concentration of 2% (v/v) in PBS. A sample solution (0.2 ml) was mixed with rabbit erythrocytes (0.2 ml) and incubated at 37[degrees]C for 30 min before centrifugation at 14,000 x g for 30s. The amount of hemoglobin released from disrupted erythrocytes was determined spectropho-tometrically. One hundred percent hemolysis was defined as [OD.sub.540] of hemoglobin released from erythrocytes treated with 0.1% Triton X-100. One hemolysin unit (HU) was defined as the reciprocal of amount of hemolysin (in mg) eliciting 50% hemoglobin release (Andreeva et al. 2006).

Effects of temperature and pH on hemolytic activity

A solution of purified lebbeckalysin in capped 1.5-ml microcentrifuge tubes was incubated in PBS(pH 7.5) at various temperatures (4,25,40,50,60,70,80,90 and 100[degrees]C) for 15 min. In another experiment, the incubation was conducted in buffers at various pH values (pH 0-14) at 25[degrees]C for 15 min. The tubes were then cooled down to room temperature or neutralized to pH 7, immediately before assay of hemolytic activity.

Effects of different carbohydrates on hemolytic activity

The carbohydrates tested included D-glucosamine, mannitol, D-xylose, sucrose, D-fucose, D-raffinose, [alpha]-lactose, D-fructose, L-arabinose, D-galacturonic acid, D-galactose, D-mannose, d-glucuronic acid, D-glucose and D-sorbitol. A serial two-fold dilution of the carbohydrate solution in microtiter U-plates (50 [mu]1) was mixed with a solution of lebbeckalysin (25 [mu]l) with 16 HU at room temperature for 30 min. Then a 50 [mu]l 2% suspension of rabbit erythrocytes was added. After further incubation for 30 min at room temperature, the concentrations of carbohydrate(s) that could inhibit the hemolysis were determined.

Effect of different ions on hemolytic activity

Ten microliters of purified lebbeckalysin (128 HU) were incubated with one of the following salts: Ag[NO.sub.3], [CaCl.sub.2], [CuCl.sub.2], [CuCl.sub.2], [FeCl.sub.3], [FeSO.sub.4], [MgCl.sub.2], [MgSO.sub.4], [MnSO.sub.4], [ZnSO.sub.4], and Na tartrate all at 1 mM at room temperature for 15 min. The mixture was diluted with 150 [micro]l deionized water. Hemolytic assay was then performed. The above salts, all 62.5 [micro]M, were tested in hemolytic assay to confirm no hemolytic effect.

Osmotic protection experiments

Polyethylene glycol (PEG) 400 (30 mM), PEG 1500 (30 mM). PEG 4000 (30 mM), PEG 6000 (15 mM), PEG 10000 (15 mM), and PEG 20000 (15 mM) with molecular diameters 0.37, 139, 366, 5.86, 9.22, and 18.59nm, respectively, were used as the osmotic protectants. Two hundred microliters of a 4% rabbit erythrocyte suspension containing an osmotic protectant were mixed with 200 [micro]1 of lebbeckalysin solution (8 HU). Protection from hemolysis was calculated as follows: protection (%) = (1 - hemolysis rate in the presence of osmotic protectant/hemolytic rate without osmotic protectant) x 100 (Berne et al. 2002).

Assay of antiproliferative activity toward tumor cells

The assay of the antiproliferative activity of lebbeckalysin was carried out by testing its inhibitory effect on the growth of human hepatoma HepG2 cells and human breast cancer MCF-7 cells as reported by Lam et al. (2009). The cells were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum and 1% penicillin-streptomycin, in a humidified atmosphere of 5% [CO.sub.2] at 37[degrees]C. The cells (10.000 cells/100 [micro]l/well) were seeded in a 96-well culture plate and serial dilutions of a solution of the lebbeckalysin, or doxorubicin (as positive control) in 100[micro]l medium were added. Medium only was added as negative control. The cells were harvested after incubation for 24 h. Standard MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was performed to determine the level of its inhibitory activity. All reported values are the means of triplicate samples.

Annexin-V and propidium iodide (PI) staining

MCF-7 cells (5 x 105) were seeded in a 6-well culture plate and treated with 0.1, 0.3 and 1 [micro]M of lebbeckalysin for 24 h. Cells without lebbeckalysin treatment (0 [micro]M) served as control. The cells were trypsinized, centrifuged (2000 x g, 4min), rinsed with PBS, and then centrifuged again (2000 x g, 4min). Cells were resus-pended in 250 [micro]l binding buffer (25 mM [CaCl.sub.2] and 140 mM NaCl in 10mM HEPES, pH 7.4). Staining solution (247 [micro]l binding buffer with 0.5 [micro]l PI (6 mg/ml) (Sigma) and 2.5 [micro]l Annexin-V solution (BD Phamingen, CA, USA)] was added. The samples were incubated in darkness at room temperature for 20 min before analysis with a FACSort flow cytometer (Becton-Dickinson, Cowley, UK). The signal was discerned by FL-1 (530 nm) channel and data were analyzed with the program WinMDI (Version 2.8, Joseph Trotter, La Jolla, CA, USA) (Lam et al., 2009).

Yeast survival assay

The survival of Candida albicans after treatment with different concentrations of lebbeckalysin for 24 h at 37[degrees]C was monitored by counting viable yeast. This was done by counting the number of colony forming units (CFUs) after appropriate dilution on LB medium and calculating their number per milliliter. Nystatin (Sigma) was used as a positive control.

Splenocyte survival assay

C57BL/6 mice (20-25 g) were killed and the spleens were aseptically removed. Spleen cells were obtained by pressing the tissue through a sterilized 100-mesh stainless steel sieve. The cells were washed with PBS twice before resuspending to a density of 1 x [10.sup.6] cells/ml in RPM1 1640 culture medium supplemented with 10% fetal bovine serum, 100 units penicillin/ml, and 100 [micro]g streptomycin/ml. The cells (1 x [10.sup.6] cells/100 [micro]l/well) were seeded into a 96-well culture plate, and serial dilutions of a solution of lebbeckalysin in 100 [micro]l medium were added. Medium only and Pleurotus eryngii hemolysin served as negative control and positive control, respectively. After incubation of the cells at 37 C for 24 h, the numbers of cells were counted. All reported values were means of triplicate samples (Wang et al. 2002). The reading of control was defined as 100% survival.

Assay of anti-fungal activity

The anti-fungal activity of lebbeckalysin was screened with an agar diffusion assay. Two hundred micrograms of lebbeckalysin were added to test its inhibitory effect on different fungi. The pathogenic fungi species used included Mycosphaerella arachidi-cola, Fusarium oxysporum, Helminthosporium maydis, Valsa mali and Rhizoctonia solani. Nystatin (Sigma) was used as a positive control. The [IC.sub.50] value for the anti-fungal activity of lebbeckalysin against R. solani was determined (Lam and Ng 2009b).

Congo red and SYTOX green staining of R. solani hyphae

Following incubation of R. solani with 80 [micro]M lebbeckalysin for 4h, Congo red or SYTOX green was added a final concentration of 50 and 5 [micro]M, respectively. For Congo red staining, fluorescence was examined 30 min later by florescent microscopy using an excitation wavelength of 543 nm and an emission wavelength of 560-635 nm. For SYTOX green staining, an excitation wavelength of 504 nm and an emission wavelength of 523 nm were used (Moreno et al. 2006). Congo red and SYTOX green were used to detect chitin deposition at hyphal tips change in membrane permeability, respectively. Purple pole bean defensin was used as a positive control (Lin et al. 2009a,b).

Microscopic view of R. solani hyphal degradation after lebbeckalysin treatment

The hyphae of R. solani were incubated with 80 [micro]M lebbeckalysin at room temperature for 4h. The hyphae were then observed under a light microscope.

Assay of anti-bacterial activity

Escherichia coli was collected in the exponential phase of growth and resuspended at a density of 1 x [10.sup.8] cells/ml with PBS (pH 7.5). Different concentrations of lebbeckalysin in 200 [micro]l of 0.2% (w/v) bovine serum albumin were then incubated in 10 [micro]l with bacterial suspension with 190 [micro]l of Luria-Bertani medium. The mixture was incubated with shaking at 37[degrees]C for 3 h. [OD.sub.600] was measured. Rachycentron canadum ovary lectin was used as a positive control (Wong et al. 2006).

Results and discussion

Fresh seeds (130g) collected locally from A lebbeck trees were homogenized in 11 of 10mM NH4HCO3 buffer (pH 8.8). The homogenate was centrifuged and the supernatant collected. The hemolysin was isolated using a protocol that entailed Q-Sepharose (anion chromatography) (Fig. 1 A), SP-Sepharose (cation chromatography) (Fig. IB), Phenyl-Sepharose (hydrophobic interaction chromatography) (Fig. 1C) and Superdex 75 10/300 GL (gel filtration) (Fig. ID). The active fractions were Ql, SP1, PS2 and S3, respectively. The purified hemolysin was designated as lebbeckalysin. Fractions S3 was chromatographed on Superdex peptide 10/300 GL and was eluted as a single homogeneous peak with the elution volume corresponding to a molecular mass of 5.5 kDa (not shown). It demonstrated a single 5.5-kDa band in SDS-PAGE (Fig. 2). The specific activity of lebbeckalysin was 13,650 hemolytic units/mg. A summary of the purification of lebbeckalysin is presented in Table 1. No sequence was obtained by sequencing on an automatic Edman degradation sequencer, suggesting the presence of a blocked N-terminus of hemolysin.
Table 1
Yields and hemolytic activity of lebbeckalysin at different stages of
purification from 130 g fresh Albizia lebbeck seeds.

     Purification stages        Chromatographic  Yield   Specific
                                   fraction       (mg)  hemolytic

Extraction                            -           1700      212

Ion-exchange chromatography on        Q1           543      572

Ion-exchange chromatography on        SP1          178     1620


Hydrophobic interaction               PS2           62     4510
chromatography on


Gel filtration on Superdex 75         S3            16   13.650

            Purification stages             Total hemolytic  Recovery
                                             activity (HU)   of HU (%)

Extraction                                      360,400

Ion-exchange chromatography on Q-Sepharose      310,600          87

Ion-exchange chromatography on                  288,400          80

Hydrophobic interaction chromatography on       279,600          76

Gel filtration on Superdex 75                   218,400          61

HU: hemolytic unit.



Hemolysins have various molecular masses; some are as small as 2.1 kDa (Staphylococcus cohnii) (Rozalska and Szewczyk, 2008), while others are larger than 100 kDa, e.g. E. coli (107 kDa) (Aldick et al. 2007), and Vibrio parahemolyticus hemolysin (118 kDa) (Sakurai et al. 1973). The molecular mass of lebbeckalysin is 5.5 kDa, which is within the lower range.

Most of the hemolysins were purified from bacteria. Some of them were isolated from animals, like fish (Zhong et al. 2006), sea anemone (Lanio et al. 2001; de Oliveira et al. 2006), jellyfish (Chung et al. 2001), toad (Gomes et al. 1994). and marine sponge (Mangel et al. 1992). There are only a few reports on hemolysin from mushrooms (Suzuki et al. 1990; Ngai and Ng 2006). The present account is the first report of hemolysin from seed.

Lebbeckalysin was incubated at different temperatures in PBS and for 15 min. In another experiment, it was incubated in buffers at different pH values at 25 C for 15 min. Afterwards, it was assayed for hemolytic activity. It demonstrated that the hemolytic activity of the lebbeckalysin was stable throughout the pH range 0-14 and in the temperature range 0-100[degrees]C after incubation for 15 min. The thermostability of most hemolysins has not been investigated. The thermostability of lebbeckalysin was the same as that of V. parahemolyticus hemolysin (Sakurai et al. 1973), which was stable at 100[degrees]C. The thermostability of P. eryngii hemolysin (eryngeolysin) is much lower, being stable only up to 40[degrees]C (Ngai and Ng. 2006). Eryngeolysin is stable over the pH range 4-12 (Ngai et al., 2006). Lebbeckalysin is stable over a wider pH range from 0 to 14. The stability of peptides is usually higher due to their confirmation stability. There are many examples of highly stable peptides, e.g. cabbage Brassica campestris anti-fungal peptide (Lin et al. 2009a,b) and Aspergillus clavatus anti-fungal peptide (Skouri-Gargouri and Gargouri 2008).

The hemolytic activity of lebbeckalysin could not be inhibited by any sugars and ions tested. The hemolytic activity of eryngeolysin is inhibited by N-glycolylneuraminic acid, [Na.sub.2] [CO.sub.3], [Na.sub.3] [PO.sub.4], [FeCl.sub.2], and [CuCl.sub.2] (Ngai et al., 2006). Ostreolysin is inhibited by [HgCl.sub.2] (Berne et al. 2002). Vibrio fluvialis hemolysin is inhibited by the chlorides of [Cd.sup.2+], [Cu.sup.2+], [Ni.sup.2+] and [Zn.sup.2+] (Han et al. 2002). However, none of carbohydrates or ions could protect the red blood cells from lebbeckalysin.

Hemolysis induced by lebbeckalysin could not be protected by any PEG tested. Hemolysis induced by eryngeolysin is osmot-ically protected by PEG 10000 with a mean hydrated diameter close to 9.3 nm (Ngai et al., 2006). Hemolysis induced by V. fluvialis hemolysis is osmotically protected by a mean hydrated diameter of 2.8-3.7 nm (Han et al. 2002). Leptospira interrogans hemolysin-mediated hemolysis is osmotically protected by PEG 5000 (Lee et al. 2002). Hemolysis induced by lebbeckalysin could not be protected by any PEG tested, indicating that hemolysis induced by the hemolysin cannot be osmotically protected by a mean hydrated diameter from 0.32 to 18.59 nm.

Lebbeckalysin inhibited proliferation of MCF-7 and HepG2 tumor cells with an [IC.sub.50] 0.97 and 1.32 [micro]M, respectively (Fig. 3). By comparison, the positive control doxorubicin exhibited an antiproliferative activity toward these tumor cells with an [IC.sub.50] of 0.3 and 8.2 [micro]M. respectively (Table 2). Asp-hemolysin (Kumagai et al. 2001), ostreolysin (Sepcic et al. 2003) and eryngeolysin (Ngai et al., 2006) exert an antiproliferative effect on different cell lines. The mechanism of anti-tumor activity was deduced by direct microscopic observations. Certain tumor cell lines exposed to ostreolysin colloid-osmotic alteration show swelling, blebbing and degranula-tion of cells (Sepcic et al. 2003).
Table 2
Comparison of biological potencies of lebbeckalysin. doxorubicin,
nystatin and Rachycentron canadum ovary lectin. Results represent mean
[+ or -]SD (N - 3).

                               Lebbeckalysin         Doxorubicin
                              ([IC.sub.50] in     ([IC.sub.50] in
                                 [micro]M)            [micro]M)

Antiproliferative activity   1.32 [+ or -] 0.25  8.2 [+ or -] 2.1
against HepG2 cells

Antiproliferative activity   0.97 [+ or -] 0.12  0.99 [+ or -] 0.09
against MCF-7 cells

Suppression of splenocyte    0.21 [+ or -] 0.02  ND

Anti-fungal activity           39 [+ or -] 3     ND
against R. solani

Inhibitory activity against  16.9 [+ or -] 12    ND
C. albicans

Inhibitory activity against  0.52 [+ or -] 0.03  ND
E. coli

                       Nystatin          Pleurotus      Rachycentron
                   ([IC.sub.50] in        eryngii      canadum ovary
                      [micro]M)          hemolysin         lectin
                                     ([IC.sub.50] in  ([IC.sub.50] in
                                         [micro]M)        [micro]M)

Antiproliferative  ND                ND               ND
activity against
HepG2 cells

Antiproliferative  ND                ND               ND
activity against
MCF-7 cells

Suppression of     ND                22 [+ or -] 0.4  ND
splenocyte growth

Anti-fungal        15.6 [+ or -] 12  ND               ND
activity against
R. solani

Inhibitory         1.3 [+ or -] 0.1  ND               ND
activity against
C. albicans

Inhibitory         ND                ND               10.5 [+ or -] 12
activity against
E. coli

ND: not determined.


Incubation of 1 [micro]M lebbeckalysin for 24 h led to an increase of 13.4% in the number of apoptotic cells and 20.5% in the number of necrotic cells (Fig. 4). The mechanism involved is probably colloid-osmotic alternation (Sepcic et al. 2003). The results from annexin-V and propidium iodide staining of MCF-7 cells further have disclosed that the cells undergo necrosis. This result is greatly different from Pleurotus nebrodensis hemolysin (nebrodeolysin)-induced apopto-sis in L929 and HeLa cells (Lv et al., 2008).


Lebbeckalysin suppressed the growth of splenocytes with an [IC.sub.50] of 0.21 [micro]M (Fig. 5). Both eryngeolysin (Ngai et al., 2006) and lebbeckalysin suppress the growth of splenocytes. The mechanism involved is also probably colloid-osmotic alternation (Sepcic et al. 2003).


Lebbeckalysin inhibited mycelial growth in R. solani with an IC50 of 39 [micro]M (Fig. 6) but there was no effect on M. arachidicola, F. oxys-porum, H. maydis, and V. matt when tested up to 200 [micro]g in agar diffusion assay (not shown). There was neither Congo red staining in the hyphal tips of R. solani nor SYTOX green staining in the hyphae (not shown), while the result of positive control was similar with those previously reported. There are two major action mechanisms for anti-fungal proteins, including chitin deposition at hyphal tips and alteration of fungal membrane permeability. However, there was neither chitin deposition at hyphal tips of R. solani nor changes in membrane permeability as evidenced by lack of Congo red or SYTOX green staining in the hyphae. On the other hand, hyphal degradation in R. solani was observed after incubation with 80 [micro]M lebbeckalysin for 4h (Fig. 7). It may be due to the pore-forming property of lebbeckalysin, which causes the degradation of fungal cell wall and ultimately hyphal disintegration. To date, none of the hemolysins has been reported to have anti-fungal activity. Lebbeckalysin exerted an anti-fungal action on R. solani, though there was no activity against four other fungal species tested. This finding is reminiscent of the observations that the shallot anti-fungal protein ascalin (Wang et al., 2002) and the anti-fungal amidase from Peltophorum pterocarpum (Lam and Ng 2009a) exert an anti-fungal action on only one out of the several fungi examined.



Lebbeckalysin inhibited the growth of C. albicans with an IC50 value of 16.9 p.M (Fig. 8). The number of Candida infections has been increasing over the period of several decades, especially for the elderly, critically ill patients, and immunosuppressed patients. As a consequence, some common superficial infections, such as oropharyngeal candidoses, in addition to serious deep candidoses have become important clinical problems (Ellepola and Samaranayake 2000). Furthermore, due to improper use of antibiotics and more invasive therapeutic medical procedures, C. albicans has developed resistance against commonly used anti-fungal agents (Richardson 2005). Information about growth inhibition of yeast by hemolysins is unavailable. The present report constitutes the first demonstration of growth inhibition of yeast by hemolysin.


Lebbeckalysin can inhibit the growth of E. coli with an IC50 value of 0.52 [micro]M (Fig. 9). Eryngeolysin does not exert anti-bacterial activity toward E. coli, but can suppress Bacillus megatarium and Bacillus subtilis (Ngai et al., 2006). To the best of our knowledge, no bacterial hemolysins have been reported with anti-bacterial activity. In fact, most of the hemolysins originate from bacteria. This is probably the reason for only a very limited number of hemolysins with anti-bacterial activity.


Arsenic is a well-known notoriously poisonous metalloid. Nevertheless, it has a tremendous therapeutic potential. Arsenic compounds have been shown to have an antiproliferative effect on hepatoma (Jiang et al. 2009), cervical cancer and human pulmonary adenocarcinoma (Han et al. 2010), etc. More recently, arsenic triox-ide has been used to cure acute promyelocytic leukemia (Malhotra et al. 2010). The probable usage of lebbeckalysin may disclose its potential medical application by its antiproliferative, anti-bacterial, anti-fungal, and anti-yeast properties, although it also suppressed the growth of splenocytes.

In summary, this is the first report of a hemolysin from plant seeds. Lebbeckalysin is robust in that it is not denatured in extreme pH and temperatures. It is the first hemolysin demonstrated to have anti-fungal and anti-yeast activities. Furthermore, lebbeckalysin displays strong anti-tumor and anti-bacterial activities. It also suppresses the growth of splenocytes.


Abe, M., Nakazawa, T., 1994. Characterization of hemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia. Microbiol. Immunol. 38, 1-9.

Aldick, T., Bielaszewska. M., Zhang, W., Brockmeyer. J.. Schmidt, H., Friedrich, A.W.. Kim, K, S., Schmidt. MA. Karch, H., 2007. Hemolysin from Shiga toxin-negative Escherichia coli 026 strains injures microvascular endothelium. Microbes Infect. 9, 282-290.

Alouf, J.E., 2001. Pore-forming bacterial protein toxins: an overview. Curr. Top. Microbiol. Immunol. 257, 1-14.

Amit. A. Saxena. V.S., Pratibha, N., D'Souza. P., Bagchi, M., Bagchi. D.. Stohs, S.J., 2003. Mast cell stabilization, lipoxygenase inhibition, hyaluronidase inhibition, antihistaminic and antispasmodic activities of Aller-7, a novel botanical formulation for allergic rhinitis. Drugs Exp. Clin. Res. 29, 107-115.

Andreeva, Z.I., Nesterenko, V.F., Yurkov, I.S., Budarina, Z.I., Sineva, E.V., Solonin, AS., 2006. Purification and cytotoxic properties of Bacillus cereus hemolysin II. Protein Exp. Purif. 47, 186-193.

Babu, N.P., Pandikumar, P., Ignacimuthu, S., 2009. Anti-inflammatory activity of Albizia lebbeck Benth., an ethnomedicinal plant, in acute and chronic animal models of inflammation. J. Ethnopharmacol. 125. 356-360.

Berne, S., Krizaj. I., Pohleven, F., Tuck, T., Macek, P., Sepcic, K., 2002. Pleurotus and Agrocybe hemolysins, new proteins hypothetically improved in fungal fruiting. Biochim, Biophys, Acta 1570, 153-159.

Berne, S., Lah, L, Sepcic, K., 2009. Aegerolysins: structure, function, and putative biological role. Protein Sci. 18, 694-706.

Chung J. J., Ratnapala, LA., Cooke, I.M., Yanagihara, A A, 2001. Partial purification and characterization of a hemolysin (CAH1) from Hawaiian box jellyfish (Carybdea alata) venom. Toxicon 39, 981-990.

de Oliveira, J.S., Zaharenko, A.J., de Freitas, J.C., Konno. K., de Andrade, SA, Por-taro, F.C.. Richardson, M.. Sant'anna, OA. Tambourgi. D.V., 2006. Caissarolysin I (Bcs 1). a new hemolytic toxin from the Brazilian sea anemone Bunodosoma caissarum: purification and biological characterization. Biochim. Biophys. Acta 1760,453-461.

Ellepola, A.N., Samaranayake. LP., 2000. Oral candidal infections and antimycotics. Crit. Rev. Oral Biol. Med. 11, 172-198.

el-Mousallamy. AM., 1998. Leaf flavonoids of Albizia Iebbeck. Phytochemistry 48. 759-761.

Gomes, A., Alam, M.I., Auddy, B., Dasgupta, S.C., 1994. Isolation, purification and partial characterization of a haemolytic protein from Bidder's organ of toad Bufo melanostictus (Schneider). Indian J. Exp. Biol. 32, 119-123.

Gupta. R.S., Chaudhary, R., Yadav, R.K., Verma, S.K., Dobhal, M.P., 2005. Effect of saponins of Albizia Iebbeck (L) Benth bark on the reproductive system of male albino rats. J. Ethnopharmacol. 96, 31-36.

Gupta. R.S., Kachhawa, J.B., Chaudhary, R., 2006. Antispermatogenic, antiandro-genic activities of Albizia Iebbeck (L) Benth bark extract in male albino rats. Phytomedicine 13, 277-283.

Han, J.H., Lee, J.H., Choi. Y.H.. Park, J.H., Choi. T.J., Kong, I.S., 2002. Purification, characterization and molecular cloning of Vibrio fluvialis hemolysin. Biochim. Biophys. Acta 1599, 106-114.

Han, Y.H., Moon. H.J., You. B.R.. Kim. S.Z., Kim, S.H., Park, W.H., 2010. Effects of arsenic trioxide on cell death, reactive oxygen species and glutathione levels in different cell types. Int. J. Mol. Med. 25, 121-128.

Jiang, H., Ma. Y., Chen, X., Pan, S., Sun, B., Krissansen, G.W., Sun, X., 2009. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Cancer Sci., Epub.

Kumagai, T., Nagata. T., Kudo. Y., Fukuchi. Y., Ebina, K., Yokota, K., 2001. Cytotoxic activity and cytokine induction of Asp-hemolysin to vascular endothelial cells. Yakugaku Zasshi 121, 271-275.

Lam, S.K., Ng, T.B., 2009a. First report of an antifungal amidase from Peltophorum ptercoarpum. Biomed. Chromatogr., Epub.

Lam. S.K., Ng. T.B., 2009b. A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper (Capparis spinosa) seeds. Phytomedicine 16, 444-450.

Lam, S.K., Han, Q.F., Ng, T.B., 2009. Isolation and characterization of a lectin with potentially exploitable activities from caper (Capparis spinosa) seeds. Biosci. Rep. 29, 293-299.

Lanio, M.E., Morera, V., Alvarez, C. Tejuca, M., Gomez, T., Pazos. F., Besada, V., Martinez, D., Huerta, V., Padron, G., de los Angeles Chavez, M., 2001. Purification and characterization of two hemolysins from Stichodactyla helianthus. Toxicon 39, 187-194.

Lee, S.H., Kim, S., Park, S.C., Kim. M.J., 2002. Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells. Infect. Immun. 70, 315-322.

Lin, P.. Wong. J.H., Ng, T.B., 2009a. A defensin with highly potent antipathogenic activities from the seeds of purple pole bean. Biosci. Rep. 30, 101-109.

Lin. P., Wong, J.H., Xia, L., Ng, T.B., 2009b. Campesin. a thermostable antifungal peptide with highly potent antipathogenic activities. J. Biosci. Bioeng. 108, 259-265.

Lv, H., Kong, Y., Yao. Q., Zhang, B., Leng, F.W., Bian, H.J., Balzarini, J., Van Damme. E.. Bao, J.K., 2008. Nebrodeolysin. a novel hemolytic protein from mushroom Pleurotus nebrodensis with apoptosis-inducing and anti-HIV-1 effects. Phytomedicine 16, 198-205.

Malhotra, P., Varma, N., Arora, N., Das, R., Nath, A., Patel, F.D., Varma, S., 2010. Treatment of therapy related acute promyelocytic leukemia with the combination of all trans retinoic acid and arsenic trioxide without chemotherapy: a series of three patients. Leuk. Lymphoma. Epub.

Mangel, A., Leito, J.M., Batel, R., Zimmermann, H., Miiller, W.E., Schrdder. H.C., 1992. Purification and characterization of a pore-forming protein from the marine sponge Tethya lyncurium. Eur. J. Biochem. 210, 499-507.

Moreno. A.B., Martinez Del Pozo, A., San Segundo. B., 2006. Biotechnologically relevant enzymes and proteins. Antifungal mechanism of the Aspergillus giganteus AFP against the rice blast fungus Magnaporthegrisea. Appl. Microbiol. Biotechnol. 72. 883-895.

Mudenda Hang'ombe, B., Kohda, T., Mukamoto, M., Kozaki. S.. 2006. Purification and sensitivity of Clostridium chauvoei hemolysin to various erythrocytes. Comp. Immunol. Microbiol. Infect. Dis. 29, 263-268.

Ngai, P.H., Ng. T.B., 2006. A hemolysin from the mushroom Pleurotus eryngii. Appl. Microbiol. Biotechnol. 72, 1185-1191.

Pal, B.C., Achari, B., Yoshikawa, K., Arihara, S., 1995. Saponins from Albizia lebbeck. Phytochemistry 38, 1287-1291.

Richardson, M.D., 2005. Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 56, 15-i11. Rozalska, M., Szewczyk, E.M., 2008. Staphylococcus cohnii hemolysins-isolation, purification and properties. Folia. Microbiol. (Praha) 53, 521-526.

Saha, A., Ahmed. M., 2009. The analgesic and anti-inflammatory activities of the extract of Albizia lebbeck in animal model. Pak. J. Pharm. Sci. 22, 74-77.

Sakurai, J., Matsuzaki, A., Miwatani, T., 1973. Purification and characterization of thermostable direct hemolysin of Vibrio parahaemolyticus. Infect. Immun. 8. 775-780.

Sepcic. K., Berne. S., Potrich. C, Turk. T., Macek. P., Menestrina. G.. 2003. Interaction of ostreolysin, a cytolytic protein from the edible mushroom Pleurotus ostreatus. with lipid membranes and modulation by lysophospholipids. Eur. J. Biochem. 270.1199-1210.

Singh. AN., Zeng, D.H., Chen, F.S., 2005. Heavy metal concentrations in redeveloping soil of mine spoil under plantations of certain native woody species in dry tropical environment. India J. Environ. Sci. (China) 17, 168-174.

Skouri-Gargouri, H., Gargouri, A., 2008. First isolation of a novel thermostable antifungal peptide secreted by Aspergillus clavatus. Peptides 29. 1871-1877.

Sritharan, M., 2006. Iron and bacterial virulence. Indian J. Med. Microbiol. 24. 163-164.

Suzuki, K., Une, T., Yamazaki, M., Takeda, T., 1990. Purification and some properties of a hemolysin from the poisonous mushroom Rhodophyllus rhodopolius. Toxicon 28,1019-1028.

Wang. H., Ng. T.B., Liu. Q., 2002. Isolation of a new heterodimeric lectin with mito-genic activity from fruiting bodies of the mushroom Agrocybe cylindracea. Life Sci. 70.877-885.

Wong. J.H., Zhang. X.Q., Wang, H.X., Ng, T.B., 2006. A mitogenic defensin from white cloud beans (Phaseolus vulgaris). Peptides 27, 2075-2081.

Zhong. Y., Zhang, X.H., Chen, J., Chi. Z.. Sun. B.. Li. Y.. Austin. B.. 2006. Overexpression, purification, characterization, and pathogenicity of Vibrio harveyi hemolysin VHH. Infect. Immun. 74, 6001-6005.

Sze Kwan Lam *, Tzi Bun Ng *

School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong China

* Corresponding authors. Tel.: +852 26098031; fax: +852 26035123.

E-mail addresses: (S.K. Lam), (T.B. Ng).

doi: 10.1016/j.phymed.2010.08.009
COPYRIGHT 2011 Urban & Fischer Verlag
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Lam, Sze Kwan; Ng, Tzi Bun
Publication:Phytomedicine: International Journal of Phytotherapy & Phytopharmacology
Article Type:Report
Geographic Code:9CHIN
Date:May 15, 2011
Previous Article:Kava extract, an herbal alternative for anxiety relief, potentiates acetaminophen-induced cytotoxicity in rat hepatic cells.
Next Article:Mechanisms involved in the antinociception of petroleum ether fraction from the EtOH extract of Chrysanthemum indicum in mice.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters